Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Taipei Veterans General Hospital (TPVGH) will utilize the Philips IntelliSite Pathology Solution to transform its pathology tissue examination to digital diagnostics. 
Opinion Article by Shane Tickell, Chief Executive, IMS MAXIMSFrom this we had learned that £850 million of this will pay for the "20 hospital upgrades" that Boris Johnson promised as he entered Number 10 Downing Street for the first time.
Milton Keynes University Hospital (MKUH) has become the first NHS Trust to introduce an information sharing tool which aims to protect women at risk of suffering female genital mutilation (FGM). The Female Genital Mutilation-Information Sharing (FGM-IS) solution is a tool which allows relevant, authorised healthcare professionals and administrative staff in the region to view information about girls with a family history of FGM, providing an opportunity to safeguard at-risk patients. 
A technology company that has helped NHS hospitals in England and Scotland to quickly identify and respond to their sickest patients, will now be known as Alcidion. Patientrack, which is known for providing technology for electronic patient observations and early warnings of patient deterioration to the NHS, first announced it had been acquired by Alcidion Group Limited in 2018. 
Allscripts has been included on a new list of accredited suppliers of electronic patient records that has been published by NHS England and NHSX. The company is one of just eight vendors listed on lot one of the Health Systems Support Framework, which is expected to become one of the main routes for NHS trusts to procure digital services, software and infrastructure. 
Isansys Lifecare is proud to announce it has been shortlisted in the Most Transformative Digital Healthcare Company category at the OBN Annual Awards 2019. The award recognises the significant uptake of the technology by healthcare providers and the real impact Isansys' technology is having on patients and hospitals globally. 
Siemens Healthineers AG has entered into a merger agreement with U.S.-based Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a global technology leader for robotic-assisted vascular interventions. Under the terms of the agreement, Siemens Healthineers will acquire all fully diluted shares of Corindus for $4.28 per share in cash or $1.1 billion in total.